Literature DB >> 11369643

Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses.

X Wang1, A Kumanogoh, C Watanabe, W Shi, K Yoshida, H Kikutani.   

Abstract

CD100/Sema4D is a 150-kd transmembrane protein that belongs to the semaphorin family. The interaction of CD100 with CD72 is critical for the immune system. In CD100-deficient mice, the production of specific antibodies against T-cell-dependent antigens is severely impaired, but not against T-cell-independent antigens. Here, a functional soluble CD100 protein (sCD100) released from activated lymphocytes is reported. sCD100 was detected in culture supernatants of activated lymphocytes. Either affinity-purified from supernatants of activated T-cells, or produced as a recombinant sCD100 protein consisting of the extracellular region of the mouse CD100 fused to the human IgG1 Fc (CD100-Fc), sCD100 significantly enhanced CD40-induced B-cell responses. Furthermore, sCD100 was detected either in sera of mice immunized with T-cell-dependent antigens, or in sera of MRL/lpr mice, but not in sera of mice immunized with T-cell-independent antigens. A significant correlation was observed between the level of sCD100 and the titer of autoantibodies in the serum of MRL/lpr mice. This study's findings suggest a potential role for sCD100 in immune responses, including production of antibody, and autoimmune diseases. (Blood. 2001;97:3498-3504)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369643     DOI: 10.1182/blood.v97.11.3498

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

2.  Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.

Authors:  John R Basile; Rogerio M Castilho; Vanessa P Williams; J Silvio Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 3.  Semaphorins: a new class of immunoregulatory molecules.

Authors:  Noriko Takegahara; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 4.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 5.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

6.  The role of the Sema4d/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.

Authors:  E M Kuklina; I V Nekrasova; T V Baidina; I Y Danchenko
Journal:  Dokl Biol Sci       Date:  2014-11-05

7.  New aspects of the Seam4D-dependent control of lymphocyte activation.

Authors:  E M Kuklina; I V Nekrasova
Journal:  Dokl Biol Sci       Date:  2017-05-16

8.  Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.

Authors:  Y Du; X Wu; M Chen; W Wang; W Xv; L Ye; D Wu; J Xue; W Sun; J Luo; H Wu
Journal:  Clin Exp Immunol       Date:  2017-02-17       Impact factor: 4.330

9.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

10.  B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.

Authors:  Noriko Asano; Manabu Fujimoto; Norihito Yazawa; Senji Shirasawa; Minoru Hasegawa; Hitoshi Okochi; Kunihiko Tamaki; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.